Mission Bio Partners with S2 Genomics to Offer Robust Solid Tumor Sample Prep for Single-Cell DNA Analysis

MSKCC lab paired Tapestri and Singulator 100 to demonstrate automated nuclei extraction workflow for fast and reliable nuclei prep for single-cell DNA analysis SOUTH SAN FRANCISCO — Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced a co-marketing partnership with S2 Genomics, Inc., a leading developer of laboratory automation solutions for [...]

MIMETAS Participates in €325 Million Oncode-PACT Initiative to Accelerate and Improve Oncology Drug Development

LEIDEN, The Netherlands -- MIMETAS, a global leader in organ-on-chip-based disease models, is a partner in the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) initiative that has been granted today an amount of €325 million by the Dutch National Growth Fund. Oncode Institute will lead the Oncode-PACT consortium and its operations. With this investment, the consortium will develop [...]

Metrohm USA Celebrates 10th Annual Young Chemist Award Winner

Metrohm USA is pleased to announce the winner of its 2022 Young Chemist Award, Colby Ott. Colby is a Ph.D. candidate at West Virginia University's Forensic and Investigative Science Department in Morgantown, West Virginia, where his research centers around developing novel methods for screening seized drugs. His work aims to provide reliable and rapid detection [...]

Cell Signaling Technology becomes 1% for the Planet Lighthouse Member

BURLINGTON, Vt. and DANVERS, Mass. -- Cell Signaling Technology (CST), a discovery technology company and leading provider of antibodies, kits, and services, is the first life sciences company to join 1% for the Planet, committing to donate 1% of annual end-user product sales to support nonprofit organizations focused on the environment. Cell Signaling Technology is the first [...]

CS Genetics Appoints Chad Geringer as Vice President of Global Sales

Experienced Sales Leader to Drive Global Adoption of Disruptive Products for Single Cell Genomics SAN DIEGO, Calif. and CAMBRIDGE, UK - CS Genetics, a privately held genomics-technology company, today announced the appointment of Chad Geringer as Vice President of Global Sales. Chad will build and lead the company's global sales organization as the company launches its single [...]

Growing Needs for Analysis and Measurement, Smart “Produces,” “Stores,” and “Uses” of Hydrogen and Energy ー 2022 Masao Horiba Awards is Now Accepting Applications

The theme of 2022 Masao Horiba Award is " Analytical and measurement technologies that contribute to the use of hydrogen for a decarbonized society." Achieving carbon neutrality is globally challenged as one of the efforts toward the realization of a sustainable society.  A new energy utilization using the alternative energy such as hydrogen instead of [...]

Ampersand Capital Partners Invests in Syft Technologies, Leading SIFT-MS Solutions Provider

Wellesley, MA – Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, today announced a minority investment in Syft Technologies Limited, a world leading provider of Mass Spectrometry (SIFT-MS) solutions. Ampersand’s investment will allow Syft to accelerate their progress in the semiconductor market and develop [...]

New GMP-manufactured Cas9 Protein Enables Clinical Genome Editing Research

Gibco CTS TrueCut Cas9 Protein supports use of genome editing for research and manufacturing applications, including CAR T-cell therapy research CARLSBAD, Calif. - As researchers using genome editing tools move from basic research to clinical settings, high-quality ancillary materials and documentation are critical. To help researchers meet stringent quality requirements, Thermo Fisher Scientific introduced the [...]

Shimadzu Group Sets New CO2 Emission Reduction Targets Moving toward net zero CO2 emissions from overall business activities by 2050

Shimadzu updates its 2018 CO2 emission targets and sets a new target of practically zero emissions by 2050. As for medium-term targets, we aim to achieve more than 85% emissions cut by 2030 and 90% by 2040 compared to 2017. CO2 emissions from the use of our products at customer sites, which account for 74% of the [...]

BIONANO GENOMICS ANNOUNCES ISSUANCE OF TWO U.S. PATENTS FOR NOVEL METHODS THAT EXPAND PATENT PROTECTION FOR USES OF NANOCHANNEL ARRAYS IN GENOME ANALYSIS

SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced that the United States Patent and Trademark Office issued two new US Patents, No. 11,291,999 and No. 11,292,713 on April 5, [...]

Access IBO on Knowledge Center